Navigation Links
Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
Date:9/14/2007

HAMBURG, Germany, Sept. 14 /PRNewswire/ -- Indivumed announces today that a service agreement with Roche Diagnostics GmbH was signed. Within this agreement Indivumed will apply its automated immunohistochemistry service platform for analyzing various biomarkers and drug targets in the area of oncology. Indivumed will provide for this project a selection of tumor tissue sections from its tumor biobank as well as specifically collected clinical samples. The analysis of specific biomarkers and drug targets should enable Roche to efficiently develop novel targeted therapies for cancer.

Indivumed is a privately held biotech company focused on the generation, characterization and analysis of highly standardized biological samples from human cancer. Founded in 2002 and headquartered in Hamburg, Germany with a subsidiary in Kensington, Maryland, USA, Indivumed has cooperation agreements with all major oncological hospitals in the Hamburg metropolitan area. Indivumed's current tumor biobank of over 6500 patient-cases, collected with a mean cold ischemia time of less than eight minutes, serves as a resource for Indivumed's internal cancer research in biomarkers and primary cell drug screening as well as for the use of pharmaceutical and biopharma partners through tumor biobank access and IHC services.


'/>"/>
SOURCE Indivumed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. CDW buyer supports Berbee growth plans
2. Tech center supports energy-saving device for heat-treating plants
3. Inacom Supports Blackhawk Technology Mentor Program
4. Computer Card Supports Solo Doctor
5. Federal Funding Supports Small Business Innovation
6. Advantages of Roche Applied Science amplification products
7. Roche Diagnostics Corporation
8. Roche Diagnostics Corporation
9. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
10. Prodesse enters patent agreement with Roche
11. A prognosis for GE and Abbott Diagnostics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /P...daq: DCGN ) today announced that it has received n... the company,s common stock will be,suspended as o...d with the,Securities and Exchange Commission, whi...on Nasdaq, unless the company files an appeal to t...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstCal...aceutical company focused on developing and commer...ed today that Anthony DiTonno, President and Chief... 21st Annual Piper Jaffray Health Care Conference,...ace Hotel in New York, New York. ,, Mr. DiTonn...
(Date:11/24/2009)...TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNewswi... formerly Calotto Capital Inc., a leading provider... stem cell research and fertility clinic markets, ...or the third quarter ended September 30, 2009. , ... million compared with $1.43 million in Q3 2008, ...
(Date:11/24/2009)... Program Connects Customers with Partn...cted with DNA Genotek Products , ...NA Genotek , a leading provider of products for bi...aration, today announced its new global partner pr... for DNA Genotek,s partner community and is design...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...why Deb Rislow believes she has risen to her curre...ems for Gundersen Lutheran - at the perfect time...r been a hotter topic as the federal government tr...nd clinics apply it to reduce medical errors, cont... around long enough to have learned plenty of less...
... against potential infringers by licensing the pat...ing activity. Thanks to a recent Federal Circuit C...ce. , ,Typically, the patent owner would do this b...t a party agree to pay for a license and then nego...posals carried little risk of triggering unwanted ...
...h if the robotics engineering team from Benilde-St... had won a national championship against other hig...their competitors were seasoned college students. ...he Minneapolis-area school competed against gradua...boCup. Using robots to navigate a simulated disast...
Other Biology Technology:CIO Leadership Series: Deb Rislow, Gundersen Lutheran 2CIO Leadership Series: Deb Rislow, Gundersen Lutheran 3CIO Leadership Series: Deb Rislow, Gundersen Lutheran 4CIO Leadership Series: Deb Rislow, Gundersen Lutheran 5Patent licensing: For enforcing companies, the rules have changed 2Patent licensing: For enforcing companies, the rules have changed 3Silver linings in the cloud: America's dearth of STEM students 2Silver linings in the cloud: America's dearth of STEM students 3Silver linings in the cloud: America's dearth of STEM students 4
(Date:11/26/2009)...ts have at last worked out a way of using recordin...ird populations. This is the first time sound reco...d into accurate estimates of bird species, populat...ritish Ecological Society,s Journal of Applied Ec...ead to a major advance in our ability to monitor w...
(Date:11/26/2009)...elberg, 27 November 2009 What are the bare essent...ed to produce a cell that can survive on its own? ...nd understand how an entire organism functions as ...t scientists in a partnership between the European..., Germany, and the Centre de Regulacio Genmica (CR...
(Date:11/25/2009)... a hormone produced in the stomach, may be used to...Parkinson,s disease, Yale School of Medicine resea...ue of the Journal of Neuroscience . , Parkinson... neurons in an area of the midbrain known as the s... production. Reduced production of dopamine in la...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Sister to Sister to Host BIKE FOR THE HEART EVENT Sunday October 11th 58718 1Sister to Sister to Host BIKE FOR THE HEART EVENT Sunday October 11th 58718 2Oncolytics Biotech 28R 29 Inc Announces Phase 3 Update Conference Call 14322 1Oncolytics Biotech 28R 29 Inc Announces Phase 3 Update Conference Call 14322 2Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 1Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 2Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 3
...A investigators reviewed pharmaceutical ads in Ame...hird contained no references for medical claims; w...ial was available, only a minority of company data... the majority of original research cited in the ad... product,s manufacturer. , In one of the largest ...
...eam of Fox Chase Cancer Center scientists led by i...ed the genetic mutation that keeps a mouse strain ... called helper T cells. The report by Kappes and h...re. , Kappes, laboratory first discovered the mic...e,s laboratory animal facility in 1997. Known as "...
... the first time, researchers have,automatically gr...lution images of cells. This technical feat opens ...rgets by helping to show which,proteins cluster to...arnegie Mellon University, outperforms,existing vi...ys,Professor Robert F. Murphy, whose report, "Data...
Other Biology News:UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims 2UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims 3Fox Chase Cancer Center scientists identify immune-system mutation 2New, automated tool successfully classifies and relates proteins in unprecedented way 2
...yacrylamide gel electrophoresis (2D-PAGE) with bio...core technology platform for proteomic analysis. 2... complex samples limited only in the dynamic range...Quantitative image based analysis of separated pro...
LabWorks Analysis Software from UVP
...apor Trap Models RVT100, RVT400, RVT405DDA, RVT410... UVS400A and UVS800DDA., A non-corrosive, odorles...or use for temperatures ranging from -105 to +260 ...ability and does not evaporate. Far superior to dr...
... is a concentrated formulation of a rinsing buffer...n technology, as well as for manual immunostaining...gati M.D., Department of Pathology, University of ...ended for all the rinsing steps performed when doi...
Biology Products: